EE200200689A - Ravimkoostised - Google Patents

Ravimkoostised

Info

Publication number
EE200200689A
EE200200689A EEP200200689A EEP200200689A EE200200689A EE 200200689 A EE200200689 A EE 200200689A EE P200200689 A EEP200200689 A EE P200200689A EE P200200689 A EEP200200689 A EE P200200689A EE 200200689 A EE200200689 A EE 200200689A
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
EEP200200689A
Other languages
English (en)
Inventor
Hirsch Stefan
Karl Mayer Friedrich
Paul Carle
Guitard Patrice
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200200689A publication Critical patent/EE200200689A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
EEP200200689A 2000-06-13 2001-06-11 Ravimkoostised EE200200689A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014448.5A GB0014448D0 (en) 2000-06-13 2000-06-13 Organic compounds
PCT/EP2001/006596 WO2001095890A2 (en) 2000-06-13 2001-06-11 Oral pharmaceutical compositions containing terbinafine

Publications (1)

Publication Number Publication Date
EE200200689A true EE200200689A (et) 2004-06-15

Family

ID=9893569

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200689A EE200200689A (et) 2000-06-13 2001-06-11 Ravimkoostised

Country Status (11)

Country Link
US (1) US20050013858A1 (et)
EP (1) EP1296646A2 (et)
JP (1) JP2004503494A (et)
AU (1) AU2001285737A1 (et)
CZ (1) CZ20024040A3 (et)
EE (1) EE200200689A (et)
GB (1) GB0014448D0 (et)
HU (1) HUP0301337A3 (et)
PL (1) PL358275A1 (et)
SK (1) SK17622002A3 (et)
WO (1) WO2001095890A2 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
IT1261776B (it) * 1993-03-12 1996-06-03 Mendes Srl Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
WO1995016465A1 (en) * 1993-12-14 1995-06-22 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues

Also Published As

Publication number Publication date
GB0014448D0 (en) 2000-08-09
EP1296646A2 (en) 2003-04-02
PL358275A1 (en) 2004-08-09
HUP0301337A3 (en) 2005-04-28
SK17622002A3 (sk) 2003-05-02
WO2001095890A3 (en) 2002-05-16
JP2004503494A (ja) 2004-02-05
AU2001285737A1 (en) 2001-12-24
WO2001095890B1 (en) 2002-07-11
CZ20024040A3 (cs) 2003-04-16
HUP0301337A2 (hu) 2003-08-28
US20050013858A1 (en) 2005-01-20
WO2001095890A2 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
ATE303787T1 (de) Schergelzusammensetzungen
ITTO20010008A0 (it) Formulazione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
NO20015175D0 (no) Farmasöytisk sammensetning
AR028197A1 (es) Composiciones antitranspirantes
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE05020B1 (et) Glburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
NO20026123L (no) Farmasöytiske sammensetninger
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
PT1239832E (pt) Composicoes farmaceuticas
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20031095L (no) Farmasoytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus
EE200200689A (et) Ravimkoostised
MXPA03001857A (es) Composicones medicinales.